Literature DB >> 15957987

Increasing likelihood of further live births in HIV-infected women in recent years.

Annalisa Agangi1, Claire Thorne, Marie-Louise Newell.   

Abstract

OBJECTIVE: To examine how the subsequent childbearing of HIV-infected mothers enrolled in the European Collaborative Study (ECS) has changed over time and identify factors predictive of further childbearing.
DESIGN: Prospective cohort study.
SETTING: Centres in nine European countries included in the ECS, enrolled between end 1986 and November 2003. POPULATION: HIV-infected women (3911): 3693 with only one and 218 with subsequent live births.
METHODS: Univariable and multivariable logistic regression analyses to obtain odds ratios (OR) and 95% confidence intervals (CI). Kaplan-Meier (KM) analyses to estimate cumulative proportions of women having a subsequent live birth. MAIN OUTCOME MEASURES: Subsequent live birth.
RESULTS: In multivariable analysis adjusting for time period, ethnicity, maternal age and parity, black women were more likely [adjusted odds ratio (AOR) 2.45; 95% CI, 1.75-3.43], and women >30 years less likely (AOR 0.54, 0.37-0.80), to have a subsequent live birth. Time to subsequent live birth significantly shortened over time, with an estimated 2% of women having a subsequent live birth within 24 months of enrollment pre-1989 versus 14% in 2000-2003 (P < 0.001). Estimated time to subsequent live birth was shorter for black than for white women (P < 0.001).
CONCLUSIONS: The likelihood of subsequent live births substantially increased after 1995 and birth intervals were shorter in women on HAART and among black women. Numbers are currently too small to address the issue of advantages and disadvantages in the management of subsequent deliveries.

Entities:  

Mesh:

Year:  2005        PMID: 15957987     DOI: 10.1111/j.1471-0528.2005.00569.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  12 in total

1.  An important clinical lesson from a patient infected with HIV with diabetic nephropathy and retinopathy.

Authors:  Pasquale Martinelli; Annalisa Agangi; Matilde Sansone; Raffaele Napolitano; Giuseppe Maria Maruotti
Journal:  BMJ Case Rep       Date:  2009-02-20

Review 2.  Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges.

Authors:  Steven Nesheim; Lauren Fitz Harris; Margaret Lampe
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

3.  Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy.

Authors:  Anjali Sharma; Joseph G Feldman; Elizabeth T Golub; Julie Schmidt; Sylvia Silver; Esther Robison; Howard Minkoff
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

4.  Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.

Authors:  Shema Tariq; Claire L Townsend; Mario Cortina-Borja; Trinh Duong; Jonathan Elford; Claire Thorne; Pat A Tookey
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-01       Impact factor: 3.731

5.  Incidence, patterns, and predictors of repeat pregnancies among HIV-infected women in the United Kingdom and Ireland, 1990-2009.

Authors:  Clare E French; Mario Cortina-Borja; Claire Thorne; Pat A Tookey
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

6.  TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns.

Authors:  Elaine Cristina Cardoso; Nátalli Zanete Pereira; Gabrielle Eimi Mitsunari; Luanda Mara da Silva Oliveira; Rosa Maria S A Ruocco; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

7.  Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.

Authors:  Susie E Huntington; Claire Thorne; Loveleen K Bansi; Jane Anderson; Marie-Louise Newell; Graham P Taylor; Deenan Pillay; Teresa Hill; Pat A Tookey; Caroline A Sabin
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

8.  Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception.

Authors: 
Journal:  Antivir Ther       Date:  2010

9.  Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda.

Authors:  Angela Kaida; Lynn T Matthews; Steve Kanters; Jerome Kabakyenga; Conrad Muzoora; A Rain Mocello; Jeffrey N Martin; Peter Hunt; Jessica Haberer; Robert S Hogg; David R Bangsberg
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Upregulation of innate antiviral restricting factor expression in the cord blood and decidual tissue of HIV-infected mothers.

Authors:  Nátalli Zanete Pereira; Elaine Cristina Cardoso; Luanda Mara da Silva Oliveira; Josenilson Feitosa de Lima; Anna Cláudia Calvielli Castelo Branco; Rosa Maria de Souza Aveiro Ruocco; Marcelo Zugaib; João Bosco de Oliveira Filho; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.